[Liver function studies under the effect of 4 sequential hormonal contraceptives].
During the first cycle of treatment the influence of four forms of sequence therapy with mestranol and ethinyl estradiol as estrogen and the two gestagens chlormadinone acetate and norethisteron acetate in women at fertile age was examined for the aminotransferases (GOT and GPT), the activity of alkaline phosphatase and alpha-amylase, for the cholesterol, total bilirubin and total protein content of the serum and for the half-life period of indocyanine green. Under the application of mestranol/chlormadinon acetate an estrogen-induced increase of the activity of the alanine aminotransferase (GPT) from 6.38 units/l to 12.14 units/l may be established, after addition of the gestagen chlormadinon acetate a decrease to 5.34 units/l was to be established. Under the sequence therapy with mestranol/norethisteron acetate only an increase of the alpha1-globulin proportion was to be ascertained. All the other changes of the tested parameters including the half-life period of indocyanine green were not essential.
D000293:Adolescent; D000328:Adult; D002715:Chlormadinone Acetate / Q000008:administration & dosage; D003276:Contraceptives, Oral / Q000008:administration & dosage*; D003279:Contraceptives, Oral, Sequential / Q000008:administration & dosage*; D004997:Ethinyl Estradiol / Q000008:administration & dosage; D005260:Female; D006801:Humans; D008099:Liver / Q000187:drug effects*; D008111:Liver Function Tests; D008656:Mestranol / Q000008:administration & dosage; D009640:Norethindrone / Q000008:administration & dosage
D003276:Contraceptives, Oral; D003279:Contraceptives, Oral, Sequential; D002715:Chlormadinone Acetate; D004997:Ethinyl Estradiol; D008656:Mestranol; D009640:Norethindrone
Leberfunktionsuntersuchungen unter dem Einfluss von 4 Sequenzpräparaten zur hormonalen Kontrazeption.